Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Eyes Nanotech Standards Process With More Unknown Than Known

This article was originally published in The Tan Sheet

Executive Summary

FDA acknowledges the impact nanotechnology is making in food, dietary supplement and cosmetic products, but likely is years away from proposing regulations for its use, says Norris Alderson, the agency's associate commissioner for science

You may also be interested in...



Health Products Lead Rapidly Expanding Nanotechnology Product List

Vitamins, supplements and other health and fitness products dominate the landscape of nano-engineered consumer products, according to the Project on Emerging Nanotechnologies, a program of the Woodrow Wilson International Center for Scholars

Health Products Lead Rapidly Expanding Nanotechnology Product List

Vitamins, supplements and other health and fitness products dominate the landscape of nano-engineered consumer products, according to the Project on Emerging Nanotechnologies, a program of the Woodrow Wilson International Center for Scholars

Health Products Lead Rapidly Expanding Nanotechnology Product List

Vitamins, supplements and other health and fitness products dominate the landscape of nano-engineered consumer products, according to the Project on Emerging Nanotechnologies, a program of the Woodrow Wilson International Center for Scholars

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS101431

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel